Discovery of a DNA Topoisomerase I Inhibitor Huanglongmycin N and Its Congeners from Streptomyces sp. CB09001
- J Org Chem. 2021 Dec 3;86(23):16675-16683. doi: 10.1021/acs.joc.1c01939.
- 1. Xiangya International Academy of Translational Medicine, Central South University, Changsha, Hunan 410013, China.
- 2. Hunan Engineering Research Center of Combinatorial Biosynthesis and Natural Product Drug Discovery, Changsha, Hunan 410013, China.
- 3. National Engineering Research Center of Combinatorial Biosynthesis for Drug Discovery, Changsha, Hunan 410013, China.
Huanglongmycin (HLM) congeners G-N (7-14) were isolated from Streptomyces sp. CB09001. Among them, 10-12 possesses a tricyclic scaffold with benzene-fused pyran/pyrone, confirmed by X-ray single crystal diffraction analysis of 12. The structure-activity relationship study of 1, 13, and 14 revealed not only the stronger cytotoxicity of 14 against tested Cancer cells but also the critical role of the C-7 ethyl group of 14 in its binding to the DNA-topoisomerase I complex.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: TopoisomeraseResearch Areas: Cancer